Follow us...

 

Search News Archives

News Channels

 

Coronavirus (COVID-19)

 

View Channel

New Laboratory Products

 

View Channel

Lab News

 

View Channel

Research & Case Studies

 

View Channel

Microscopy | Image Analysis

 

View Channel

Separation Science

 

View Channel

Videos

 

View Channel

Events | Webinars

 

View Channel

Conferences | Events

NEW Rickettsia Monoclonal Antibody

publication date: Oct 4, 2018
 | 
author/source: ViroStat

Rickettsia300


Rickettsia rickettsii is an obligate intracellular gram negative bacteria that can infect humans and other invertebrates.

The most common human disease is Spotted Fever. Transmission occurs from the bite of various infected arthropods, the most common being the American dog tick and the Rocky Mountain wood tick. Typical symptoms are fever, headache and a rash. Prompt treatment with Doxycycline is recommended.

ViroStat has released a new Monoclonal Antibody to the Rickettsiae LPS. It is reactive with all members of the spotted fever group of Rickettsiae. It does not cross react with the typhus group (R. typhi or R. prowazekii). This new antibody functions in ELISA and IFA and may also function in other rapid test formats.


find out more




 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 

 

 

Media Partners